
What happened
Micron stock has jumped 220% in 2026 while Sandisk has gained 480%, but Micron sells both DRAM and NAND, with DRAM at 73% of its top line and almost $40 billion in revenue last quarter.
Why it matters
Micron's dual exposure lets it benefit from demand for both memory types, whereas Sandisk's pure-play NAND focus leaves it narrower, making Micron the better three-year pick.
Summaries like this, every morning.
Micron and Sandisk have both delivered stellar returns in 2026, driven by demand for memory chips used in AI data centers. Sandisk's 480% gain outpaces Micron's 220%, but Micron's business mix gives it an edge. Micron sells both DRAM and NAND flash, while Sandisk is a pure-play NAND manufacturer, so Micron benefits from demand across both memory types. DRAM alone produced 73% of Micron's top line last quarter, nearly $40 billion in revenue. Micron also has exposure to high-bandwidth memory, where sales are growing faster than conventional DRAM, and management has raised HBM pricing significantly for 2027. Industry signals point to widening memory shortages: ASML noted shortages are growing in size and time horizon, and SK Hynix expects DRAM undersupply to widen in 2027 with new capacity only coming online in June 2029. Those conditions suggest Micron's DRAM business is poised for healthy growth over the next three years.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
SpaceX reported revenue up 161% with positive EBITA

On the Motley Fool podcast, Ray Dalio said an AI bubble could burst relatively soon, citing higher interest ra…

S&P Global reports Q3 on Oct

Tempus AI expanded its drug development collaborations with Bristol Myers Squibb and Pathos AI

Vertiv and NVIDIA presented at GTC on how they can halve AI factory deployment time

Danaher (DHR) received FDA clearance for AI-powered atrial fibrillation detection
